Connection

Radhika Gudi to Ligands

Back to Details
This is a "connection" page, showing publications Radhika Gudi has written about Ligands.
Radhika Gudi
Connection Strength
0.524
Ligands
  1. Activation of T cell checkpoint pathways during ?-cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes. Immunology. 2022 07; 166(3):341-356.
    View in: PubMed
    Score: 0.189
  2. Centrosomal P4.1-associated protein (CPAP) positively regulates endocytic vesicular transport and lysosome targeting of EGFR. Sci Rep. 2021 06 16; 11(1):12689.
    View in: PubMed
    Score: 0.178
  3. Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance. Sci Rep. 2019 08 19; 9(1):12065.
    View in: PubMed
    Score: 0.157
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.